Short Description

NGS genetic DNA test detecets for variant and mutation detection in CD2AP gene for Focal segmental glomerulosclerosis type 3

PreTest Information

Clinical History of Patient who is going for CD2AP Gene Focal segmental glomerulosclerosis type 3 NGS Genetic DNA Test. A Genetic Counselling session to draw a pedigree chart of family members affected with CD2AP Gene Focal segmental glomerulosclerosis type 3 NGS Genetic DNA Test gene CD2AP

Detail Description

DNA Labs India: CD2AP Gene Focal Segmental Glomerulosclerosis Type 3 NGS Genetic DNA Test

Focal segmental glomerulosclerosis (FSGS) is a rare kidney disorder that affects the filtering units of the kidneys. There are different types of FSGS, and one of them is type 3, which is caused by a mutation in the CD2AP gene. DNA Labs India offers a genetic DNA test to diagnose CD2AP gene FSGS type 3, which costs INR 20,000.

Symptoms of CD2AP Gene FSGS Type 3

The symptoms of CD2AP gene FSGS type 3 are similar to other types of FSGS and may include:

• Proteinuria (excessive protein in the urine)
• Edema (swelling) in the feet, ankles, and legs
• High blood pressure
• Reduced kidney function

It is important to note that some people with CD2AP gene FSGS type 3 may not have any symptoms initially, and the condition may be detected during routine medical tests.

Diagnosis of CD2AP Gene FSGS Type 3

CD2AP gene FSGS type 3 is diagnosed through a genetic DNA test, which looks for mutations in the CD2AP gene. The test is performed using a sample of blood or saliva, and the results are usually available within a few weeks.

If the test shows a mutation in the CD2AP gene, further tests may be required to confirm the diagnosis and determine the extent of kidney damage.

Cost of CD2AP Gene FSGS Type 3 Genetic DNA Test

The cost of CD2AP gene FSGS type 3 genetic DNA test at DNA Labs India is INR 20,000. The test is not covered by insurance, and payment is usually required upfront.

Conclusion

CD2AP gene FSGS type 3 is a rare kidney disorder that can lead to kidney failure if left untreated. Early diagnosis and treatment are important to prevent complications and improve the chances of a successful outcome. The genetic DNA test offered by DNA Labs India can help diagnose CD2AP gene FSGS type 3 and guide appropriate treatment options. If you suspect you may have FSGS, speak to your doctor about getting tested.

For more information on genetic DNA testing for CD2AP gene FSGS type 3, contact DNA Labs India today.

The CD2AP gene encodes a protein called CD2-associated protein (CD2AP), which plays a role in maintaining the structural integrity of kidney podocytes, specialized cells that contribute to the structure of the glomeruli and help regulate filtration.

Mutations in the CD2AP gene can lead to certain types of FSGS, including FSGS Type 3. Genetic mutations affecting CD2AP can disrupt the normal function of kidney podocytes and contribute to the development of kidney disease.

NGS (Next-Generation Sequencing) genetic DNA tests are used to analyze the DNA sequence of genes like CD2AP to identify any mutations or variants that may be associated with FSGS Type 3.

If you or someone you know is considering genetic testing for FSGS related to the CD2AP gene, I recommend consulting with a nephrologist (kidney specialist), a medical geneticist, or a genetic counsellor. They can provide accurate and current information about the condition, the implications of genetic testing, and any available treatment options. Keep in mind that medical knowledge can evolve, so it's important to rely on expert guidance for the latest information.